Next Technology Holding Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Next Technology Holding Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.61M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.80M | Mar 31, 2026 |
| FY2023 | Dec 31, 2023 | $2.63M | Sep 9, 2024 |
| FY2022 | Dec 31, 2022 | $11.67M | Jul 14, 2023 |
| FY2022 | Dec 31, 2021 | $14.38M | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $6.27M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Mar 31, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.07M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.43M | Mar 27, 2025 |
| FY2022 | Dec 31, 2022 | $1.98M | Jul 14, 2023 |
| FY2022 | Dec 31, 2021 | $11.70M | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $5.66M | Apr 14, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $143.16M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $21.54M | Mar 31, 2026 |
| FY2023 | Dec 31, 2023 | ($9.92M) | Sep 9, 2024 |
| FY2023 | Dec 31, 2022 | ($9.16M) | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | $5.18M | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.68M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($417.4K) | Mar 31, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($80.20M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($16.8K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($1.24M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($6.79M) | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | $5.99M | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $3.75M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($417.4K) | Mar 31, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.48M | Mar 31, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.07M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $20.21M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($37.80M) | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | ($3.75M) | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.16M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($130.9K) | Mar 31, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $693.6K | Jul 14, 2023 |
| FY2022 | Dec 31, 2021 | $417.1K | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Apr 14, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $524.13M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $92.92M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $48.93M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $46.52M | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | $19.47M | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $13.54M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $6.59M | Mar 31, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.55M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.29M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.22M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $4.82M | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | $4.94M | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $4.65M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.79M | Mar 31, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $455.58M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $81.63M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $44.71M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $41.71M | Mar 27, 2025 |
| FY2023 | Dec 31, 2021 | $14.54M | Sep 9, 2024 |
| FY2022 | Dec 31, 2020 | $8.89M | Jul 14, 2023 |
| FY2021 | Dec 31, 2019 | $4.80M | Apr 14, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.33M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $9.91M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($11.64M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($1.71M) | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | $7.43M | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.26M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($417.4K) | Mar 31, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.62M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $668.4K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $668.4K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $22.9K | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | $616.6K | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | $4.64M | Apr 14, 2022 |
| FY2021 | Dec 31, 2019 | $6.59M | Apr 14, 2022 |
| FY2020 | Mar 27, 2019 | $0 | Mar 31, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 1 | Sep 9, 2024 |
| FY2023 | Dec 31, 2022 | (5) | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 14, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 2 | Sep 9, 2024 |
| FY2023 | Dec 31, 2022 | (5) | Sep 9, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.88M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 34,882 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 2.63M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 1.05M | Sep 9, 2024 |
| FY2022 | Dec 31, 2021 | 305.45M | Jul 14, 2023 |
| FY2021 | Dec 31, 2020 | 305.45M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | 300.22M | Mar 31, 2021 |